Cargando…
Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review
SIMPLE SUMMARY: Bladder cancer is the ninth most common cancer worldwide. Immune checkpoint inhibitors, a novel class of immunotherapy drugs that restore natural antitumoral immune activity, have been applied to improve the overall survival and to reduce the morbidity and mortality of bladder cancer...
Autores principales: | Barone, Biagio, Calogero, Armando, Scafuri, Luca, Ferro, Matteo, Lucarelli, Giuseppe, Di Zazzo, Erika, Sicignano, Enrico, Falcone, Alfonso, Romano, Lorenzo, De Luca, Luigi, Oliva, Francesco, Mirto, Benito Fabio, Capone, Federico, Imbimbo, Ciro, Crocetto, Felice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139497/ https://www.ncbi.nlm.nih.gov/pubmed/35626149 http://dx.doi.org/10.3390/cancers14102545 |
Ejemplares similares
-
Novel Therapeutic Opportunities in Neoadjuvant Setting in Urothelial Cancers: A New Horizon Opened by Molecular Classification and Immune Checkpoint Inhibitors
por: Iacovino, Maria Lucia, et al.
Publicado: (2022) -
Novel Key Ingredients in Urinary Tract Health—The Role of D-mannose, Chondroitin Sulphate, Hyaluronic Acid, and N-acetylcysteine in Urinary Tract Infections (Uroial PLUS(®))
por: Crocetto, Felice, et al.
Publicado: (2023) -
The Impact of Meat Intake on Bladder Cancer Incidence: Is It Really a Relevant Risk?
por: Aveta, Achille, et al.
Publicado: (2022) -
Kaempferol, Myricetin and Fisetin in Prostate and Bladder Cancer: A Systematic Review of the Literature
por: Crocetto, Felice, et al.
Publicado: (2021) -
The Efficacy of Flogofilm(®) in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
por: Barone, Biagio, et al.
Publicado: (2023)